{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "6e0d9f8b",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\aishwarya\\anaconda3\\envs\\T5\\lib\\site-packages\\tqdm\\auto.py:22: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "\n",
    "import random\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import torch\n",
    "from torch.utils.data import Dataset, DataLoader\n",
    "\n",
    "from transformers import (\n",
    "    AdamW,\n",
    "    T5ForConditionalGeneration,\n",
    "    T5Tokenizer,\n",
    "    get_linear_schedule_with_warmup\n",
    ")\n",
    "\n",
    "def set_seed(seed):\n",
    "  random.seed(seed)\n",
    "  np.random.seed(seed)\n",
    "  torch.manual_seed(seed)\n",
    "\n",
    "set_seed(42)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "056f06f5",
   "metadata": {},
   "outputs": [],
   "source": [
    "tokenizer = T5Tokenizer.from_pretrained('t5-base')\n",
    "t5_model = T5ForConditionalGeneration.from_pretrained('t5-base')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "1bb49ff1",
   "metadata": {},
   "outputs": [],
   "source": [
    "# optimizer\n",
    "no_decay = [\"bias\", \"LayerNorm.weight\"]\n",
    "optimizer_grouped_parameters = [\n",
    "    {\n",
    "        \"params\": [p for n, p in t5_model.named_parameters() if not any(nd in n for nd in no_decay)],\n",
    "        \"weight_decay\": 0.0,\n",
    "    },\n",
    "    {\n",
    "        \"params\": [p for n, p in t5_model.named_parameters() if any(nd in n for nd in no_decay)],\n",
    "        \"weight_decay\": 0.0,\n",
    "    },\n",
    "]\n",
    "optimizer = AdamW(optimizer_grouped_parameters, lr=3e-4, eps=1e-8)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "d5cdbd72",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "df = pd.read_csv(\"table_pharma_40Topics_sentenceLevel_topic_analysis_user_defined.csv\")\n",
    "\n",
    "top_sentence_list_for_topics = []\n",
    "for i in range(len(df.columns[45:])):\n",
    "    top_sentence_list_for_topics.append(df[df[df.columns[45+i]] >0.8][\"Sentences\"])\n",
    "    \n",
    "import numpy as np\n",
    "def calculate_deciles(list):\n",
    "    #create data\n",
    "    data = np.array(list)\n",
    "\n",
    "    #calculate deciles of data\n",
    "    deciles = np.percentile(data, np.arange(0, 100, 10))\n",
    "    return deciles\n",
    "\n",
    "topics_top_sentence_list = []\n",
    "for i in range(len(df.columns[5:45])):\n",
    "    column_name = df.columns[5+i]\n",
    "    column_deciles = calculate_deciles(df[column_name].tolist())\n",
    "    topics_top_sentence_list.append(df[df[df.columns[5+i]].between(column_deciles[-2],column_deciles[-1])][\"Sentences\"])\n",
    "    \n",
    "# env_data = []\n",
    "# for i in top_sentence_list_for_topics[0]:\n",
    "#     env_data.append((i,'environment'))\n",
    "# env_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "2dc0be9e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('talENtED PEOPlE We depend on the skills and creativity of our employees to discover, develop and produce new medicines, and deliver them to patients.',\n",
       "  'Environment'),\n",
       " ('Our environment We live in an era of amazing medical innovation, driven by better understanding of the genetic and biological roots of disease, and surging use of data analytics and digital technology in science and healthcare.',\n",
       "  'Environment'),\n",
       " ('We aspire to be a leader on environmental, social and governance topics and to build trust with society.',\n",
       "  'Environment'),\n",
       " ('Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.',\n",
       "  'Environment'),\n",
       " ('At the same time, we are taking steps to minimize our negative environmental impact, as measured by the carbon, other air emissions, water and waste impacts of our own opera- tions and supply chain, which were val- ued at USD 5.3 billion.',\n",
       "  'GHG Emissions'),\n",
       " ('We want to grow our business without consuming more natural resources, and our actions demonstrate it: While Novartis Group sales have increased in the past 10 years, our consumption of energy and water, as well as our greenhouse gas emissions, have declined.',\n",
       "  'GHG Emissions'),\n",
       " ('For example, we have reduced our carbon emissions (scope 1 and 2) by nearly 80 000 tonnes vs. 2016.',\n",
       "  'GHG Emissions'),\n",
       " ('Our strategy sets ambitious targets to become carbon neutral in our own operations by 2025, reduce the carbon footprint of our supply chain by at least half by 2030, and achieve plastic and water neutrality by 2030.',\n",
       "  'GHG Emissions'),\n",
       " ('Our Arogya Parivar health educa- tors will help provide detailed information about Ayushman Bharat PM-JAY ben- efits to help improve health-seeking behavior in the villages.',\n",
       "  'Air Quality'),\n",
       " ('We maintain a robust quality system with harmonized pro- cesses and procedures.',\n",
       "  'Air Quality'),\n",
       " ('We made our environmental perfor- mance more visible in the organization in 2019.',\n",
       "  'Air Quality'),\n",
       " ('Throughout the year, we continued to take steps to further reduce our envi- ronmental impact.',\n",
       "  'Air Quality'),\n",
       " ('Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.',\n",
       "  'Energy Management'),\n",
       " ('Throughout the year, we continued to take steps to further reduce our envi- ronmental impact.',\n",
       "  'Energy Management'),\n",
       " ('These have generated several energy efficiency projects that we are currently implementing, such as the optimization of boilers and chillers for heating, ventilation and air conditioning.',\n",
       "  'Energy Management'),\n",
       " ('Switch to renewable energy: We are actively investing in renewable energy sources.',\n",
       "  'Energy Management'),\n",
       " ('We are also making progress toward achieving water sustainability.',\n",
       "  'Water & Wastewater Management'),\n",
       " ('Our 2025 goal to reduce water consumption in our operations by half versus 2016 is on track, as well as our water quality target.',\n",
       "  'Water & Wastewater Management'),\n",
       " ('We are actively exploring ways to recy- cle water.',\n",
       "  'Water & Wastewater Management'),\n",
       " ('For example, we developed a technology at our site in Kurtky, Turkey, which enables us to treat and reuse wastewater in cooling towers.',\n",
       "  'Water & Wastewater Management'),\n",
       " ('Governance Waste management is overseen globally by the Waste and Dangerous Goods Center of Excellence (CoE).',\n",
       "  'Waste and Hazardous Materials Management'),\n",
       " ('Hazardous waste: Heavily regulated or high-risk waste streams that need to be neutralized, treated or destroyed to address a particular hazard such as toxicity, flammability, corrosivity, radioactivity, pharmaceutically active or infectious.',\n",
       "  'Waste and Hazardous Materials Management'),\n",
       " ('Waste Lilly generates both nonhazardous and hazardous waste from its manufacturing processes.',\n",
       "  'Waste and Hazardous Materials Management'),\n",
       " ('Growing production levels have generated increased waste volumes of both hazardous and non-hazardous waste.',\n",
       "  'Waste and Hazardous Materials Management'),\n",
       " ('We aspire to be a leader on environmental, social and governance topics and to build trust with society.',\n",
       "  'Ecological Impacts'),\n",
       " ('At the same time, we are taking steps to minimize our negative environmental impact, as measured by the carbon, other air emissions, water and waste impacts of our own opera- tions and supply chain, which were val- ued at USD 5.3 billion.',\n",
       "  'Ecological Impacts'),\n",
       " ('In 2019, through the TPRM rollout, we expanded the scope and enhanced the assessment of certain risk areas, such as labor rights and environment.',\n",
       "  'Ecological Impacts'),\n",
       " ('Migration, climate change, deforestation and urbanization are all con- tributing to the spread of leishmaniasis.',\n",
       "  'Ecological Impacts'),\n",
       " ('We also aim to reward those who invest their money, time and ideas in our company.',\n",
       "  'Social Capital'),\n",
       " ('We aspire to be a leader on environmental, social and governance topics and to build trust with society.',\n",
       "  'Social Capital'),\n",
       " ('The Novartis purpose is inherently a social one: We reimagine medicine to improve and extend peoples lives.',\n",
       "  'Social Capital'),\n",
       " ('Senior management attendance high- lighted our companys commitment to trust and reputation priorities.',\n",
       "  'Social Capital'),\n",
       " ('Chaired by our CEO, it oversees progress and aims to accel- erate decision-making in key GH&CR areas.',\n",
       "  'Human Rights and Community Relations'),\n",
       " ('Overall, we have expanded our focus on human rights risks and impacts in our supply chain and in the commu- nities where we work.',\n",
       "  'Human Rights and Community Relations'),\n",
       " ('Similarly, we found in our 2018 human rights assessment that more regular and broader consultation with external stakeholders was needed at the local level (from patient groups, local com- munities and health authorities to supply chain partners).',\n",
       "  'Human Rights and Community Relations'),\n",
       " ('Therefore, in 2019, we redesigned our human rights assessment program to include direct engagement with suppliers, communi- ties and civil society actors.',\n",
       "  'Human Rights and Community Relations'),\n",
       " ('Substantiated complaints concerning breaches of customer privacy and losses of customer data Noncompliance with laws and regulations in the social and economic area',\n",
       "  'Customer Privacy'),\n",
       " ('Data privacy and security Systems to ensure that the personally identifiable informa- tion of patients, employees, consumers and others is responsibly and securely collected, transferred and stored.',\n",
       "  'Customer Privacy'),\n",
       " ('We require these suppliers and service providers to provide appropriate privacy protection for personal information that they handle in accordance with our privacy policies and applicable privacy laws, regulations and guidelines.',\n",
       "  'Customer Privacy'),\n",
       " ('We are committed to ethical use, management and protection of information.',\n",
       "  'Customer Privacy'),\n",
       " ('This independent corporate function brings together Global Security, the SpeakUp Office and Internal Audit, ena- bling us to leverage our resources and data, providing insights and protection, and acting as cultural change agents.',\n",
       "  'Data Security'),\n",
       " ('This realization led to the launch of the TPRM program in 2016.',\n",
       "  'Data Security'),\n",
       " (' Retaliation Other employee relations issue Conflict of interest IT security breach Quality assurance/data integrity Data privacy Antitrust, fair competition Other',\n",
       "  'Data Security'),\n",
       " ('Addressing the Zolgensma data integrity issue Novartis recognizes societys increas- ing expectations of our industry and our company.',\n",
       "  'Data Security'),\n",
       " ('3 2019 highlights 4 Who we are 6 What we do 8 Message from the CEO Global Health & Corporate Responsibility at Novartis 9 13 Strategic areas Holding ourselves to the highest ethical standards 13 20 Being part of the solution onpricing and access 32 Addressing global healthchallenges 39 Being a responsible citizen 50 About this report 51 Performance indicators 2019 55 Novartis GRI Content Index Appendix: corporate responsibility material topic boundaries 59 Appendix: corporate responsibility materiality assessment issue cluster andtopic definitions Appendix: external initiatives and membership of associations Appendix: supplier spend 2019 Appendix: the responsible procurement (RP) risk indicator tool Appendix: measuring and valuing our impact Independent Assurance Report onthe 2019 Novartis in Society ESGreporting',\n",
       "  'Access and Affordability'),\n",
       " ('We use innovative science and technology to address some of societys most challenging healthcare issues.',\n",
       "  'Access and Affordability'),\n",
       " ('We also aim to reward those who invest their money, time and ideas in our company.',\n",
       "  'Access and Affordability'),\n",
       " ('We partner with external organizations to ac- celerate drug discov- ery, develop business oppor tunities and ex- pand patient access.',\n",
       "  'Access and Affordability'),\n",
       " ('At no time during the investigation did the findings indi- cate issues with product safety, efficacy or quality.',\n",
       "  'Product Quality and Safety'),\n",
       " ('Novartis is currently developing a child-friendly formulation of hydroxyurea that would',\n",
       "  'Product Quality and Safety'),\n",
       " ('Helping ensure patient health and safety Our patient health and safety activities are focused on three key areas: patient safety and product quality, combating counterfeit medicines, and health edu- cation and prevention.',\n",
       "  'Product Quality and Safety'),\n",
       " ('MaiNtaiNiNG PatiENt SaFEty aNd PRoduCt Quality Patient safety and product quality are our top priorities.',\n",
       "  'Product Quality and Safety'),\n",
       " ('We also aim to reward those who invest their money, time and ideas in our company.',\n",
       "  'Customer Welfare'),\n",
       " ('In this section Read about our efforts to protect the safety of those using our medicines, care for our people and minimize our impact on the environment:',\n",
       "  'Customer Welfare'),\n",
       " ('We are focused on building a company that our customers, associates, share- holders and partners can all be proud of.',\n",
       "  'Customer Welfare'),\n",
       " ('We seek to have a positive impact on the lives of our employees, their families and the communities in which we operate along with our suppliers in support of our customers.',\n",
       "  'Customer Welfare'),\n",
       " ('Consequently, we want to make certain that the ways in which we market and sell our products to our customershealth care professionals, health insurers and governmentsinclude accurate, balanced and useful information so that prescribers can make the best decisions for their patients.',\n",
       "  'Selling Practices and Product Labeling'),\n",
       " ('Product label reviews The ongoing oversight and monitoring of our product labels are a major focus of our safety efforts.',\n",
       "  'Selling Practices and Product Labeling'),\n",
       " ('*** As communicated through the product label, SIRTURO is taken for six months as part of a combination therapy with multiple other drugs; in total, a patient often requires up to two years of treatment to be cured.',\n",
       "  'Selling Practices and Product Labeling'),\n",
       " ('We are leveraging the label update for Victoza achieved on the basis of results from the LEADER trial, which showed that liraglutide is associated with significant cardiovascular risk reduction in people with type 2 diabetes.',\n",
       "  'Selling Practices and Product Labeling'),\n",
       " ('We also aim to reward those who invest their money, time and ideas in our company.',\n",
       "  'Human Capital'),\n",
       " ('CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.',\n",
       "  'Human Capital'),\n",
       " ('Our people The greatest strength of Novartis is our people, whose diversity, energy and creativity are crucial to our success.',\n",
       "  'Human Capital'),\n",
       " ('Our annual progress and aspirations for the future are reflected in this report, which is organized around our four key GH&CR focus areas:',\n",
       "  'Human Capital'),\n",
       " ('We were industry leaders in labor practice indicators covering D&I, equal remu- neration, and freedom of association.',\n",
       "  'Labor Practices'),\n",
       " ('Fair working conditions Ensuring fair employment practices, including upholding labor rights to freedom of association and collective bar- gaining, labor relations and union practices, and fair com- pensation and benefits.',\n",
       "  'Labor Practices'),\n",
       " ('Supplier assessment for labor practices and human rights We have a formal program to evaluate the risks for labor and human rights in our supply chain.',\n",
       "  'Labor Practices'),\n",
       " ('Our SAQ requires suppliers to answer a series of labor and human rights questions covering a range of subjects, including freely chosen employment, child labor, employment practices, employee disclosures, fair treatment, wages, benefits and working hours.',\n",
       "  'Labor Practices'),\n",
       " (' New employee hires and employee turnover Types of injury and rates of injury, occupational diseases, lost days and absenteeism, and number of work-related fatalities',\n",
       "  'Employee Health and Safety'),\n",
       " ('Workers with high incidence or high risk of diseases related to their occupation Health and safety topics covered in formal agreements with trade unions Average hours of training per year, per employee Programs for upgrading employee skills and transition assistance programs Diversity of governance bodies and employees Operations and suppliers at significant risk for incidents of forced or compulsory labor',\n",
       "  'Employee Health and Safety'),\n",
       " ('Health and safety Ensuring the health and safety of associates.',\n",
       "  'Employee Health and Safety'),\n",
       " ('This includes efforts to reduce fatalities, injuries and sick leave, and to promote well-being through health programs.',\n",
       "  'Employee Health and Safety'),\n",
       " ('Our people The greatest strength of Novartis is our people, whose diversity, energy and creativity are crucial to our success.',\n",
       "  'Employee Engagement, Diversity and Inclusion'),\n",
       " ('This realization led to the launch of the TPRM program in 2016.',\n",
       "  'Employee Engagement, Diversity and Inclusion'),\n",
       " ('We are constantly learning and remain committed to not only meet- ing but exceeding these expectations as we endeavor to increase our positive impact everywhere we work.',\n",
       "  'Employee Engagement, Diversity and Inclusion'),\n",
       " ('including 178 women, have completed the two-year training, and 70% work as com- munity paramedics.',\n",
       "  'Employee Engagement, Diversity and Inclusion'),\n",
       " ('Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       "  'Business Model and Innovation'),\n",
       " ('We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.',\n",
       "  'Business Model and Innovation'),\n",
       " ('We are rethinking how we work, embracing agile teams and building better productivity into our company to free resources that we can invest in innovation and help boost returns.',\n",
       "  'Business Model and Innovation'),\n",
       " ('As a global innovator, we strive to expand our focus beyond financial results to create long-term value along our entire value chain.',\n",
       "  'Business Model and Innovation'),\n",
       " ('focusing on sustainable design, material use efficiency, reduction in product packaging, and managing product end-of-life impacts;',\n",
       "  'Product Design and Lifecycle Management'),\n",
       " ('Our approach is based on science and a lifecycle accountability for product impactsfrom discovery and design, raw material sourcing and manufacturing to product use and end of life.',\n",
       "  'Product Design and Lifecycle Management'),\n",
       " ('From early discovery, through drug development and while a drug is on the market, Lilly works to ensure the safe and effective use of its medicine.',\n",
       "  'Product Design and Lifecycle Management'),\n",
       " ('Similarly, the life cycle teams that comprise a variety ofexperts and decide upon the future development ofa product began to work differently.',\n",
       "  'Product Design and Lifecycle Management'),\n",
       " ('After the platform was launched, several participating pharmacies with higher initial list prices quickly reduced their prices to be more competitive with our preferred pharmacy.',\n",
       "  'Business Model Resilience'),\n",
       " ('These countries were selected because they are large enough for social business models to scale up and be sus- tainable over time.',\n",
       "  'Business Model Resilience'),\n",
       " ('Novartis Healthy Family The Novartis Healthy Family programs are innovative business models that are expanding access to community edu- cation, improved infrastructure and affordable healthcare products for peo- ple living at the base of the income pyr- amid in a way that is sustainable.',\n",
       "  'Business Model Resilience'),\n",
       " ('Zipline is already operating two distribution centers in Ghana, with plans to open two more in the near future.',\n",
       "  'Business Model Resilience'),\n",
       " ('At the same time, Novartis engages with an extensive network of suppliers worldwide.',\n",
       "  'Supply Chain Management'),\n",
       " ('In addi- tion, we maintain a strong commitment to upholding human rights and manag- ing risk in our supply chain.',\n",
       "  'Supply Chain Management'),\n",
       " ('Managing risk in our supply chain One of our key risk areas is within our supply chain and our interactions with third parties.',\n",
       "  'Supply Chain Management'),\n",
       " ('Under this new operating model, we believe we will be able to continuously scan for new risks, proactively take cor- rective measures where needed, and deliver continuous improvement in our supply chain.',\n",
       "  'Supply Chain Management'),\n",
       " ('We continue to reduce waste and increase material efficiency even as we provide more medicines to a growing number of patients.',\n",
       "  'Materials Sourcing and Efficiency'),\n",
       " ('This year we also brought on a new technology partner, SupplyShift, to help us improve the accuracy and efficiency in our wood-fiber products sourcing.',\n",
       "  'Materials Sourcing and Efficiency'),\n",
       " ('Working closely with the local supplier of cardboard packaging, the design was adapted to make the cardboard boxes suitable for return and reuse.',\n",
       "  'Materials Sourcing and Efficiency'),\n",
       " ('The new method of separation of the two powders enabled us to reduce waste of large volumes of titanium powder, a finite resource, thereby improving the sustainability of our production process and reducing manufacturing waste.',\n",
       "  'Materials Sourcing and Efficiency'),\n",
       " ('The objective was to provide a business perspective to policymakers in order to validate the need to monetize carbon, encourage adoption of technologies that decar- bonize energy, and raise understanding of the physical risks climate change poses to business.',\n",
       "  'Physical Impacts of Climate Change'),\n",
       " ('Some of the potential impacts of climate change to its business include increased operating costs due to additional regulatory requirements, physical risks to the companys facilities, water limitations and disruptions to its supply chain.',\n",
       "  'Physical Impacts of Climate Change'),\n",
       " ('The World Economic Forums \"Global Risks Report 2020,\" the 15th such report, notes that for the first time in the history of the Global Risks Perception Survey environmental concerns dominate the top long-term risks.',\n",
       "  'Physical Impacts of Climate Change'),\n",
       " ('We are preparing for the risks and oppor- tunities which will arise from changing weather patterns, sea level rises and other climate impacts.',\n",
       "  'Physical Impacts of Climate Change'),\n",
       " ('We aspire to be a leader on environmental, social and governance topics and to build trust with society.',\n",
       "  'Leadership and Governance'),\n",
       " ('Additionally, with the Ghanaian government and the Sickle Cell Foundation of Ghana, we launched a first-of-its-kind partnership to improve care for people with sickle cell disease.',\n",
       "  'Leadership and Governance'),\n",
       " ('Chaired by our CEO, it oversees progress and aims to accel- erate decision-making in key GH&CR areas.',\n",
       "  'Leadership and Governance'),\n",
       " ('The event was hosted by our CEO and included our Chief Ethics, Risk & Compliance Officer, as well as the Group Head of Global Health & Corporate Responsibility and the Chief Operating Officer for Global Health.',\n",
       "  'Leadership and Governance'),\n",
       " ('Senior management attendance high- lighted our companys commitment to trust and reputation priorities.',\n",
       "  'Business Ethics'),\n",
       " ('We want to grow our business without consuming more natural resources, and our actions demonstrate it: While Novartis Group sales have increased in the past 10 years, our consumption of energy and water, as well as our greenhouse gas emissions, have declined.',\n",
       "  'Business Ethics'),\n",
       " ('In 2019, we launched Novartis Plastic- Free Workplace and, as a first symbolic move, we asked all associates to adopt refillable bottles and all sites to provide',\n",
       "  'Business Ethics'),\n",
       " ('Ethical business practices 4.1.', 'Business Ethics'),\n",
       " ('Breaches of competition law are not tolerated and can lead to disciplinary and other actions, including termination of employment.',\n",
       "  'Competitive Behavior'),\n",
       " ('It focuses increasingly on segments where it can make a real difference, either by making available the most competitive generic alterna- tive or by offering a novel and more affordable alternative to existing thera- pies (e.g., leading biologic medicines through its global biosimilar business).',\n",
       "  'Competitive Behavior'),\n",
       " ('After the platform was launched, several participating pharmacies with higher initial list prices quickly reduced their prices to be more competitive with our preferred pharmacy.',\n",
       "  'Competitive Behavior'),\n",
       " ('In 2019, we launched a tiered pricing strategy based on household wealth, and spe- cific distribution channels to reach dif- ferent income segments with our branded and generic medicines.',\n",
       "  'Competitive Behavior'),\n",
       " ('These changes aim to continue to drive fair, timely and thorough investi gations of both local and higher-risk cases to pro- tect Novartis associates, patients, cus- tomers, assets, brands and reputation.',\n",
       "  'Management of the Legal & Regulatory Environment'),\n",
       " ('It is with this mindset that we approached the situation when, in August, the US Food and Drug Administration (FDA) released a statement addressing data integrity issues with the regulatory submission for Zolgensma, our gene therapy for spi- nal muscular atrophy.',\n",
       "  'Management of the Legal & Regulatory Environment'),\n",
       " ('development of new healthcare products, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally, including potential regulatory actions or delays with respect to the proposed transactions or the development of the products described in this Novartis In Society ESG Report; uncertainties regarding actual or potential legal proceedings, including, among others, litigation or other legal disputes with respect to the proposed transactions, product liability litigation, litigation and investigations regarding sales and marketing practices, intellectual property disputes and government investigations generally; our reliance on outsourcing key business functions to third parties; our ability to comply with data privacy laws and regulations, and uncertainties regarding potential significant breaches of data privacy; safety, quality, data integrity or manufacturing issues; uncertainties involved in the development or adoption of potentially transforma- tional technologies and business models; the potential that the strategic benefits, synergies or opportunities expected from our recent and proposed future transactions may not be realized or may take longer to realize than expected; the uncertainties involved in predicting shareholder returns; our performance on environmental, social and governance measures; political, economic and trade conditions, including uncertainties regarding the effects of ongoing instability in various parts of the world; uncertainties regarding the effects of recent and anticipated future changes in tax laws and their application to us; uncertainties regarding future global exchange rates; uncertainties regarding future demand for our products; and other risks and factors referred to in Novartis AGs current Form 20-F on file with the US Securities and Exchange Commission.',\n",
       "  'Management of the Legal & Regulatory Environment'),\n",
       " ('Our interactions with providers, other customers and consumers are governed by laws and regulations, and by our long-standing global Code of Conduct, Our Values & Standards.',\n",
       "  'Management of the Legal & Regulatory Environment'),\n",
       " ('In Rwanda, where citizens are potentially at risk from the Ebola outbreak in neighboring DRC, we are providing up to 200,000 investigational Ebola vaccine regimens (which has been conditionally approved in Rwanda) to support a new immunization program led by the Government of Rwanda.',\n",
       "  'Critical Incident Risk Management'),\n",
       " ('This realization led to the launch of the TPRM program in 2016.',\n",
       "  'Systemic Risk Management'),\n",
       " ('By systematically maintaining rigorous attention to sustainable risk management principles and controls, we can do a better job of protecting our stakeholders worldwide, enabling the organization to focus on discovering, developing, and providing innovative products and services that save and improve human and animal lives around the world.',\n",
       "  'Systemic Risk Management'),\n",
       " ('Managing the associated risks rigorously and systematically is key in order for us to create and protect value over the short, medium and long term.',\n",
       "  'Systemic Risk Management'),\n",
       " ('The FDA granted priority review for risdiplam forSMA.',\n",
       "  'Systemic Risk Management')]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_data= []\n",
    "for i in range(len(top_sentence_list_for_topics)):\n",
    "    count = -1\n",
    "    for j in top_sentence_list_for_topics[i]:\n",
    "        if count == 3:\n",
    "            break\n",
    "        else:\n",
    "            train_data.append((j,df.columns[45+i]))\n",
    "            count = count+1\n",
    "train_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "0b057c35",
   "metadata": {},
   "outputs": [],
   "source": [
    "sentence_short_phrases = train_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "dfff53ae",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "epoch  0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\aishwarya\\anaconda3\\envs\\T5\\lib\\site-packages\\transformers\\tokenization_utils_base.py:2263: FutureWarning: The `pad_to_max_length` argument is deprecated and will be removed in a future version, use `padding=True` or `padding='longest'` to pad to the longest sequence in the batch, or use `padding='max_length'` to pad to a max length. In this case, you can give a specific length with `max_length` (e.g. `max_length=45`) or leave max_length to None to pad to the maximal input size of the model (e.g. 512 for Bert).\n",
      "  warnings.warn(\n",
      "C:\\Users\\aishwarya\\anaconda3\\envs\\T5\\lib\\site-packages\\transformers\\models\\t5\\tokenization_t5.py:194: UserWarning: This sequence already has </s>. In future versions this behavior may lead to duplicated eos tokens being added.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "epoch  1\n",
      "epoch  2\n",
      "epoch  3\n",
      "epoch  4\n",
      "epoch  5\n",
      "epoch  6\n",
      "epoch  7\n",
      "epoch  8\n",
      "epoch  9\n"
     ]
    }
   ],
   "source": [
    "t5_model.train()\n",
    "\n",
    "epochs = 10\n",
    "\n",
    "for epoch in range(epochs):\n",
    "  print (\"epoch \",epoch)\n",
    "  for input,output in sentence_short_phrases:\n",
    "    input_sent = \"shorten: \"+input+ \" </s>\"\n",
    "    ouput_sent = output+\" </s>\"\n",
    "\n",
    "    tokenized_inp = tokenizer.encode_plus(input_sent,  max_length=96, pad_to_max_length=True,return_tensors=\"pt\",truncation=True)\n",
    "    tokenized_output = tokenizer.encode_plus(ouput_sent, max_length=96, pad_to_max_length=True,return_tensors=\"pt\",truncation=True)\n",
    "\n",
    "\n",
    "    input_ids  = tokenized_inp[\"input_ids\"]\n",
    "    attention_mask = tokenized_inp[\"attention_mask\"]\n",
    "\n",
    "    lm_labels= tokenized_output[\"input_ids\"]\n",
    "    decoder_attention_mask=  tokenized_output[\"attention_mask\"]\n",
    "\n",
    "\n",
    "    # the forward function automatically creates the correct decoder_input_ids\n",
    "    output = t5_model(input_ids=input_ids, labels=lm_labels,decoder_attention_mask=decoder_attention_mask,attention_mask=attention_mask)\n",
    "    loss = output[0]\n",
    "\n",
    "    loss.backward()\n",
    "    optimizer.step()\n",
    "    optimizer.zero_grad()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "efd84dc2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[8        We also aim to reward those who invest their m...\n",
       " 19        tEChNOlOGY We use artificial intelligence, ge...\n",
       " 29       We develop and produce innovative medicines to...\n",
       " 42       In our pursuit of trans- formative treatments,...\n",
       " 43       We are rethinking how we work, embracing agile...\n",
       "                                ...                        \n",
       " 12773     corroborate the qualitative information (acti...\n",
       " 12780     for the key performance indicators and other ...\n",
       " 12804     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12806     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12812     20-F: Item 4, B.1., Strategy 20-F: Item 4, B....\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 9        Novartis Pharmaceuticals Novartis Pharmaceutic...\n",
       " 27       Our products Our products address most major d...\n",
       " 35       The rise in the average yearly number of new d...\n",
       " 37       The projected number of people in the world ag...\n",
       "                                ...                        \n",
       " 12783    Those procedures were conducted at a selection...\n",
       " 12784    We believe that the procedures performed, base...\n",
       " 12791    We believe that the procedures performed, base...\n",
       " 12803    in the United States) f) Number of countries i...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 30       We also offer about 1 000 generic and bio- sim...\n",
       " 49       Thank you for taking the time to learn more ab...\n",
       " 59       Related to responsible citizenship, we made si...\n",
       " 62       We understand our contri- butions must be part...\n",
       " 84       These topics are at the core of the four GH&CR...\n",
       "                                ...                        \n",
       " 12808     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12811     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12812     20-F: Item 4, B.1., Strategy 20-F: Item 4, B....\n",
       " 12824                : +33 (0)1 53 77 40 00 www.sanofi.com\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 5        We reimagine medicine to improve and extend pe...\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 42       In our pursuit of trans- formative treatments,...\n",
       " 44       We aim to spark a digital revolution at Novart...\n",
       " 47       We aspire to be a leader on environmental, soc...\n",
       "                                ...                        \n",
       " 12715    The lost time injury frequency rate is the num...\n",
       " 12743    The data presented correspond to effluents aft...\n",
       " 12752    This is a free translation into English of the...\n",
       " 12754    In our capacity as (i) an independent third pa...\n",
       " 12773     corroborate the qualitative information (acti...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 23       FINaNCIal CaPItal We use cash, equity and debt...\n",
       " 28       Our manufacturing facilities produced 72 billi...\n",
       "                                ...                        \n",
       " 12805    g) Net sales 3-year trend in net sales Net sal...\n",
       " 12806     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12807     20-F: Item 4, B.5., Global Research & Develop...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12813    Other topics cited in Article L225-102-1 III o...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 18       NatURal CaPItal We consume energy, e r water a...\n",
       " 21       RElatIONshIPs We work with doctors to get effe...\n",
       " 24       INtEllECtUal CaPItal We use expertise and data...\n",
       " 29       We develop and produce innovative medicines to...\n",
       " 30       We also offer about 1 000 generic and bio- sim...\n",
       "                                ...                        \n",
       " 12768    we verified that the Statement includes each c...\n",
       " 12775    For the other risks, we performed our procedur...\n",
       " 12787    Based on our procedures, we have not identifie...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12821    English translation and language consultancy: ...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 0        3 2019 highlights 4 Who we are 6 What we do 8 ...\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 12       CORPORATE FUNCTIONS support the enterprise in ...\n",
       " 43       We are rethinking how we work, embracing agile...\n",
       "                                ...                        \n",
       " 12790    The sample selected represents 25% of the work...\n",
       " 12800    Corporate social responsibility cross-referenc...\n",
       " 12811     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12815    Biopiracy Personal data protection Employee he...\n",
       " 12816     4.2.6.2., Policy and action plans 4.2.7.1.2.,...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 5        We reimagine medicine to improve and extend pe...\n",
       " 6        We use innovative science and technology to ad...\n",
       " 10       NOVARTIS TECHNICAL OPERATIONS (NTO) is respons...\n",
       "                                ...                        \n",
       " 12707     Le@rn, a system dedicated to training in good...\n",
       " 12722    This is because for a given injury, the number...\n",
       " 12727    Accidents in public transport or taxis are exc...\n",
       " 12801    SEFP topic Business model Business environment...\n",
       " 12813    Other topics cited in Article L225-102-1 III o...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 14       The Novartis Institutes for BioMedical Researc...\n",
       " 49       Thank you for taking the time to learn more ab...\n",
       " 56       We made significant progress in global health,...\n",
       " 59       Related to responsible citizenship, we made si...\n",
       " 81       We conducted our third global materiality asse...\n",
       "                                ...                        \n",
       " 12788    For the Selected Information as identified by ...\n",
       " 12797    Number of suppliers subject to a CSR performan...\n",
       " 12800    Corporate social responsibility cross-referenc...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12815    Biopiracy Personal data protection Employee he...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 20       g INFRastRUCtURE aND FaCIlItIEs We own or leas...\n",
       " 37       The projected number of people in the world ag...\n",
       " 45       We strive to build trust with society through ...\n",
       " 47       We aspire to be a leader on environmental, soc...\n",
       " 58       Focusing on ethical behavior, we rolled out an...\n",
       "                                ...                        \n",
       " 12782     substantive tests using sampling techniques, ...\n",
       " 12797    Number of suppliers subject to a CSR performan...\n",
       " 12804     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12812     20-F: Item 4, B.1., Strategy 20-F: Item 4, B....\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 10       NOVARTIS TECHNICAL OPERATIONS (NTO) is respons...\n",
       " 12       CORPORATE FUNCTIONS support the enterprise in ...\n",
       " 14       The Novartis Institutes for BioMedical Researc...\n",
       " 39       As we implement our strategy, we have five pri...\n",
       "                                ...                        \n",
       " 12780     for the key performance indicators and other ...\n",
       " 12784    We believe that the procedures performed, base...\n",
       " 12785    Our procedures involved eleven professional st...\n",
       " 12787    Based on our procedures, we have not identifie...\n",
       " 12791    We believe that the procedures performed, base...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 19        tEChNOlOGY We use artificial intelligence, ge...\n",
       " 33       At the same time, the worlds population contin...\n",
       " 75       We are committed to taking real, meas- urable ...\n",
       " 84       These topics are at the core of the four GH&CR...\n",
       " 86       Chaired by our CEO, it oversees progress and a...\n",
       "                                ...                        \n",
       " 12788    For the Selected Information as identified by ...\n",
       " 12792    In our opinion, we have not identified any mat...\n",
       " 12794    Quantitative information (including key perfor...\n",
       " 12819    Occupational injury/disease indicators 4.2.14....\n",
       " 12824                : +33 (0)1 53 77 40 00 www.sanofi.com\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 66       Over the past 20 years, our company has evolve...\n",
       " 68       Our strategy rests on five pillars and is root...\n",
       " 74       Our annual progress and aspirations for the fu...\n",
       " 79       One way we approach this is through our corpor...\n",
       " 84       These topics are at the core of the four GH&CR...\n",
       "                                ...                        \n",
       " 12791    We believe that the procedures performed, base...\n",
       " 12797    Number of suppliers subject to a CSR performan...\n",
       " 12801    SEFP topic Business model Business environment...\n",
       " 12806     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12816     4.2.6.2., Policy and action plans 4.2.7.1.2.,...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 6        We use innovative science and technology to ad...\n",
       " 30       We also offer about 1 000 generic and bio- sim...\n",
       " 35       The rise in the average yearly number of new d...\n",
       " 36       The projected value of the global digital heal...\n",
       " 39       As we implement our strategy, we have five pri...\n",
       "                                ...                        \n",
       " 12765    Our procedures as described below were perform...\n",
       " 12768    we verified that the Statement includes each c...\n",
       " 12770     we verified that the Statement presents the i...\n",
       " 12773     corroborate the qualitative information (acti...\n",
       " 12778    with article L. 233-16 of the French Commercia...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 43       We are rethinking how we work, embracing agile...\n",
       " 51       Our ESG-related commitments are not add-ons to...\n",
       " 61       Theres much more to share, and our 2019 report...\n",
       " 62       We understand our contri- butions must be part...\n",
       " 63       I hope the following pages will inspire you to...\n",
       "                                ...                        \n",
       " 12780     for the key performance indicators and other ...\n",
       " 12782     substantive tests using sampling techniques, ...\n",
       " 12787    Based on our procedures, we have not identifie...\n",
       " 12792    In our opinion, we have not identified any mat...\n",
       " 12821    English translation and language consultancy: ...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 52       In 2019, we established a Trust & Reputation C...\n",
       " 83       Within these clusters, priority topics were id...\n",
       " 84       These topics are at the core of the four GH&CR...\n",
       " 98       NGOs, government agencies, private sector firm...\n",
       " 99       In May, our CEO addressed the annual Shared Va...\n",
       "                                ...                        \n",
       " 12777    all the companies included in the scope of con...\n",
       " 12780     for the key performance indicators and other ...\n",
       " 12787    Based on our procedures, we have not identifie...\n",
       " 12792    In our opinion, we have not identified any mat...\n",
       " 12813    Other topics cited in Article L225-102-1 III o...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 12       CORPORATE FUNCTIONS support the enterprise in ...\n",
       " 39       As we implement our strategy, we have five pri...\n",
       " 49       Thank you for taking the time to learn more ab...\n",
       " 59       Related to responsible citizenship, we made si...\n",
       " 76       We are also determined to learn from and share...\n",
       "                                ...                        \n",
       " 12784    We believe that the procedures performed, base...\n",
       " 12785    Our procedures involved eleven professional st...\n",
       " 12791    We believe that the procedures performed, base...\n",
       " 12797    Number of suppliers subject to a CSR performan...\n",
       " 12805    g) Net sales 3-year trend in net sales Net sal...\n",
       " Name: Sentences, Length: 1283, dtype: object,\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 21       RElatIONshIPs We work with doctors to get effe...\n",
       " 51       Our ESG-related commitments are not add-ons to...\n",
       " 59       Related to responsible citizenship, we made si...\n",
       " 63       I hope the following pages will inspire you to...\n",
       "                                ...                        \n",
       " 12760     the fairness of the information provided purs...\n",
       " 12796    Total quantity of hazardous waste Quantity of ...\n",
       " 12811     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12816     4.2.6.2., Policy and action plans 4.2.7.1.2.,...\n",
       " 12819    Occupational injury/disease indicators 4.2.14....\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 20       g INFRastRUCtURE aND FaCIlItIEs We own or leas...\n",
       " 27       Our products Our products address most major d...\n",
       " 40       We are transforming our culture to ensure peop...\n",
       " 48       In the long run, thats what will enable us to ...\n",
       "                                ...                        \n",
       " 12747    Waste arising from soil decontamination operat...\n",
       " 12771     we verified that the Statement presents the b...\n",
       " 12786    We conducted about thirty interviews with the ...\n",
       " 12796    Total quantity of hazardous waste Quantity of ...\n",
       " 12801    SEFP topic Business model Business environment...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 12       CORPORATE FUNCTIONS support the enterprise in ...\n",
       " 51       Our ESG-related commitments are not add-ons to...\n",
       " 52       In 2019, we established a Trust & Reputation C...\n",
       " 59       Related to responsible citizenship, we made si...\n",
       "                                ...                        \n",
       " 12792    In our opinion, we have not identified any mat...\n",
       " 12794    Quantitative information (including key perfor...\n",
       " 12802    b) Prescribers c) Competition d) Regulatory fr...\n",
       " 12818     4.2.6.3., Performance indicators 4.2.7.1.3., ...\n",
       " 12820    Performance indicators 4.2.14.3.2., Water Cons...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 6        We use innovative science and technology to ad...\n",
       " 9        Novartis Pharmaceuticals Novartis Pharmaceutic...\n",
       " 11       NOVARTIS BUSINESS SERVICES (NBS) consolidates ...\n",
       "                                ...                        \n",
       " 12734     emissions generated by the production of stea...\n",
       " 12743    The data presented correspond to effluents aft...\n",
       " 12808     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12811     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12812     20-F: Item 4, B.1., Strategy 20-F: Item 4, B....\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 3        Cover photo Patients at Kumasi General Hospita...\n",
       " 4        Only about 4% of babies in Ghana are tested fo...\n",
       " 5        We reimagine medicine to improve and extend pe...\n",
       "                                ...                        \n",
       " 12820    Performance indicators 4.2.14.3.2., Water Cons...\n",
       " 12821    English translation and language consultancy: ...\n",
       " 12822               Photo credit: Front cover: Benot Rajau\n",
       " 12823         54, rue La Botie 75008 Paris - France - Tel.\n",
       " 12824                : +33 (0)1 53 77 40 00 www.sanofi.com\n",
       " Name: Sentences, Length: 11542, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 4        Only about 4% of babies in Ghana are tested fo...\n",
       " 19        tEChNOlOGY We use artificial intelligence, ge...\n",
       " 20       g INFRastRUCtURE aND FaCIlItIEs We own or leas...\n",
       " 27       Our products Our products address most major d...\n",
       "                                ...                        \n",
       " 12808     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12812     20-F: Item 4, B.1., Strategy 20-F: Item 4, B....\n",
       " 12820    Performance indicators 4.2.14.3.2., Water Cons...\n",
       " 12822               Photo credit: Front cover: Benot Rajau\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 6        We use innovative science and technology to ad...\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 10       NOVARTIS TECHNICAL OPERATIONS (NTO) is respons...\n",
       " 15       NIBR focuses on discovering new drugs that can...\n",
       " 27       Our products Our products address most major d...\n",
       "                                ...                        \n",
       " 12792    In our opinion, we have not identified any mat...\n",
       " 12797    Number of suppliers subject to a CSR performan...\n",
       " 12798    Measures taken in ethics and business integrit...\n",
       " 12808     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12819    Occupational injury/disease indicators 4.2.14....\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 4        Only about 4% of babies in Ghana are tested fo...\n",
       " 5        We reimagine medicine to improve and extend pe...\n",
       " 21       RElatIONshIPs We work with doctors to get effe...\n",
       " 24       INtEllECtUal CaPItal We use expertise and data...\n",
       "                                ...                        \n",
       " 12736    We have updated emission factors by using fact...\n",
       " 12742    it includes our production sites, R&D sites an...\n",
       " 12754    In our capacity as (i) an independent third pa...\n",
       " 12797    Number of suppliers subject to a CSR performan...\n",
       " 12808     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 24       INtEllECtUal CaPItal We use expertise and data...\n",
       " 33       At the same time, the worlds population contin...\n",
       " 45       We strive to build trust with society through ...\n",
       " 52       In 2019, we established a Trust & Reputation C...\n",
       "                                ...                        \n",
       " 12771     we verified that the Statement presents the b...\n",
       " 12772     assess the process for selecting and validati...\n",
       " 12793    Health and safety in the workplace* Measures t...\n",
       " 12813    Other topics cited in Article L225-102-1 III o...\n",
       " 12816     4.2.6.2., Policy and action plans 4.2.7.1.2.,...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 3        Cover photo Patients at Kumasi General Hospita...\n",
       " 11       NOVARTIS BUSINESS SERVICES (NBS) consolidates ...\n",
       " 18       NatURal CaPItal We consume energy, e r water a...\n",
       " 21       RElatIONshIPs We work with doctors to get effe...\n",
       " 24       INtEllECtUal CaPItal We use expertise and data...\n",
       "                                ...                        \n",
       " 12760     the fairness of the information provided purs...\n",
       " 12783    Those procedures were conducted at a selection...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12820    Performance indicators 4.2.14.3.2., Water Cons...\n",
       " 12822               Photo credit: Front cover: Benot Rajau\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 9        Novartis Pharmaceuticals Novartis Pharmaceutic...\n",
       " 30       We also offer about 1 000 generic and bio- sim...\n",
       " 37       The projected number of people in the world ag...\n",
       " 43       We are rethinking how we work, embracing agile...\n",
       "                                ...                        \n",
       " 12771     we verified that the Statement presents the b...\n",
       " 12772     assess the process for selecting and validati...\n",
       " 12785    Our procedures involved eleven professional st...\n",
       " 12797    Number of suppliers subject to a CSR performan...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 15       NIBR focuses on discovering new drugs that can...\n",
       " 55       We also announced plans to shift from maximiz-...\n",
       " 56       We made significant progress in global health,...\n",
       " 60       Our teams also took important steps to help en...\n",
       " 101      In September, we held our sixth ESG investor e...\n",
       "                                ...                        \n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12813    Other topics cited in Article L225-102-1 III o...\n",
       " 12818     4.2.6.3., Performance indicators 4.2.7.1.3., ...\n",
       " 12819    Occupational injury/disease indicators 4.2.14....\n",
       " 12820    Performance indicators 4.2.14.3.2., Water Cons...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 6        We use innovative science and technology to ad...\n",
       " 7        We discover and develop breakthrough treatment...\n",
       " 22       We partner with external organizations to ac- ...\n",
       " 23       FINaNCIal CaPItal We use cash, equity and debt...\n",
       " 27       Our products Our products address most major d...\n",
       "                                ...                        \n",
       " 12680    It will however be possible to make like-for-l...\n",
       " 12684    It will however be possible to make like-for-l...\n",
       " 12772     assess the process for selecting and validati...\n",
       " 12773     corroborate the qualitative information (acti...\n",
       " 12780     for the key performance indicators and other ...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 20       g INFRastRUCtURE aND FaCIlItIEs We own or leas...\n",
       " 28       Our manufacturing facilities produced 72 billi...\n",
       " 40       We are transforming our culture to ensure peop...\n",
       " 53       Building trust with society has been elevated ...\n",
       "                                ...                        \n",
       " 12785    Our procedures involved eleven professional st...\n",
       " 12788    For the Selected Information as identified by ...\n",
       " 12792    In our opinion, we have not identified any mat...\n",
       " 12806     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12807     20-F: Item 4, B.5., Global Research & Develop...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 11       NOVARTIS BUSINESS SERVICES (NBS) consolidates ...\n",
       " 32       Our environment We live in an era of amazing m...\n",
       " 39       As we implement our strategy, we have five pri...\n",
       " 42       In our pursuit of trans- formative treatments,...\n",
       "                                ...                        \n",
       " 12626    SDG 5.5: Ensure womens full and effective part...\n",
       " 12637    are consolidated worldwide for all Sanofi comp...\n",
       " 12661    introducing self-service to enhance the user e...\n",
       " 12673    The method used to integrate companies acquire...\n",
       " 12685    This is why to the extent possible, we specify...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 3        Cover photo Patients at Kumasi General Hospita...\n",
       " 9        Novartis Pharmaceuticals Novartis Pharmaceutic...\n",
       " 21       RElatIONshIPs We work with doctors to get effe...\n",
       " 28       Our manufacturing facilities produced 72 billi...\n",
       " 30       We also offer about 1 000 generic and bio- sim...\n",
       "                                ...                        \n",
       " 12773     corroborate the qualitative information (acti...\n",
       " 12778    with article L. 233-16 of the French Commercia...\n",
       " 12792    In our opinion, we have not identified any mat...\n",
       " 12821    English translation and language consultancy: ...\n",
       " 12823         54, rue La Botie 75008 Paris - France - Tel.\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 10       NOVARTIS TECHNICAL OPERATIONS (NTO) is respons...\n",
       " 27       Our products Our products address most major d...\n",
       " 35       The rise in the average yearly number of new d...\n",
       " 44       We aim to spark a digital revolution at Novart...\n",
       " 66       Over the past 20 years, our company has evolve...\n",
       "                                ...                        \n",
       " 12722    This is because for a given injury, the number...\n",
       " 12745    The data reported cover all Sanofi sites other...\n",
       " 12772     assess the process for selecting and validati...\n",
       " 12785    Our procedures involved eleven professional st...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 3        Cover photo Patients at Kumasi General Hospita...\n",
       " 10       NOVARTIS TECHNICAL OPERATIONS (NTO) is respons...\n",
       " 11       NOVARTIS BUSINESS SERVICES (NBS) consolidates ...\n",
       " 33       At the same time, the worlds population contin...\n",
       "                                ...                        \n",
       " 12759    In addition, we have implemented a quality con...\n",
       " 12775    For the other risks, we performed our procedur...\n",
       " 12788    For the Selected Information as identified by ...\n",
       " 12790    The sample selected represents 25% of the work...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 6        We use innovative science and technology to ad...\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 10       NOVARTIS TECHNICAL OPERATIONS (NTO) is respons...\n",
       " 14       The Novartis Institutes for BioMedical Researc...\n",
       "                                ...                        \n",
       " 12677     our change in HR platform from Convergence to...\n",
       " 12724    The total occupational injury frequency rate i...\n",
       " 12725    A motor vehicle accident is any accident that ...\n",
       " 12772     assess the process for selecting and validati...\n",
       " 12811     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 15       NIBR focuses on discovering new drugs that can...\n",
       " 18       NatURal CaPItal We consume energy, e r water a...\n",
       " 24       INtEllECtUal CaPItal We use expertise and data...\n",
       " 35       The rise in the average yearly number of new d...\n",
       " 37       The projected number of people in the world ag...\n",
       "                                ...                        \n",
       " 12786    We conducted about thirty interviews with the ...\n",
       " 12798    Measures taken in ethics and business integrit...\n",
       " 12809    Suppliers/Subcontractors Total amount of purch...\n",
       " 12821    English translation and language consultancy: ...\n",
       " 12822               Photo credit: Front cover: Benot Rajau\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 12       CORPORATE FUNCTIONS support the enterprise in ...\n",
       " 51       Our ESG-related commitments are not add-ons to...\n",
       " 59       Related to responsible citizenship, we made si...\n",
       " 69       1 Guide the implementation of the Novartis Acc...\n",
       " 97       The event brought together more than 160 atten...\n",
       "                                ...                        \n",
       " 12802    b) Prescribers c) Competition d) Regulatory fr...\n",
       " 12804     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12806     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12808     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " 12811     20-F: Item 4, B.2., Main pharmaceutical produ...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 1        Photo A worker at Ziplines distribution center...\n",
       " 4        Only about 4% of babies in Ghana are tested fo...\n",
       " 5        We reimagine medicine to improve and extend pe...\n",
       " 15       NIBR focuses on discovering new drugs that can...\n",
       " 22       We partner with external organizations to ac- ...\n",
       "                                ...                        \n",
       " 12771     we verified that the Statement presents the b...\n",
       " 12775    For the other risks, we performed our procedur...\n",
       " 12780     for the key performance indicators and other ...\n",
       " 12804     20-F: Item 4, B.6.1., Marketing and distribut...\n",
       " 12805    g) Net sales 3-year trend in net sales Net sal...\n",
       " Name: Sentences, Length: 1282, dtype: object,\n",
       " 2        Novartis has partnered with Zipline, a US-base...\n",
       " 8        We also aim to reward those who invest their m...\n",
       " 41       Were creating an organization where people are...\n",
       " 49       Thank you for taking the time to learn more ab...\n",
       " 51       Our ESG-related commitments are not add-ons to...\n",
       "                                ...                        \n",
       " 12727    Accidents in public transport or taxis are exc...\n",
       " 12786    We conducted about thirty interviews with the ...\n",
       " 12793    Health and safety in the workplace* Measures t...\n",
       " 12805    g) Net sales 3-year trend in net sales Net sal...\n",
       " 12812     20-F: Item 4, B.1., Strategy 20-F: Item 4, B....\n",
       " Name: Sentences, Length: 1282, dtype: object]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "topics_top_sentence_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "396d668f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " ' tEChNOlOGY We use artificial intelligence, gene editing and other cutting-edge tech- nologies to spur innovation and increase efficiency.',\n",
       " 'We develop and produce innovative medicines to address patient needs in disease areas where our experience and knowledge have the potential to produce transformative treatments.',\n",
       " 'In our pursuit of trans- formative treatments, we challenge medical paradigms and explore possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to dramatically improve quality of life.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'Novartis Pharmaceuticals Novartis Pharmaceuticals focuses on patented treat - ments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.',\n",
       " 'Our products Our products address most major disease areas and are sold in approximately 155 countries around the world.',\n",
       " 'The rise in the average yearly number of new drugs approved by the US FDAs Center for Drug Evaluation and Research from 2015-2019, compared to 2010-2014',\n",
       " 'We also offer about 1 000 generic and bio- similar medicines covering a broad range of therapeutic areas.',\n",
       " 'Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.',\n",
       " 'Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.',\n",
       " 'We understand our contri- butions must be part of a larger social movement, as the challenges society faces are too great for any group or government to solve alone.',\n",
       " 'We reimagine medicine to improve and extend peoples lives.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'In our pursuit of trans- formative treatments, we challenge medical paradigms and explore possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to dramatically improve quality of life.',\n",
       " 'We aim to spark a digital revolution at Novartis, embracing digital tech- no logies, advanced analytics and artificial intelligence to help drive innovation and improve efficiency.',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'FINaNCIal CaPItal We use cash, equity and debt to meet our financial com- mitments, make investments and pay dividends.',\n",
       " 'NatURal CaPItal We consume energy, e r water and other resources to manu- facture our products and operate our business.',\n",
       " 'RElatIONshIPs We work with doctors to get effective treat- ments to patients.',\n",
       " 'INtEllECtUal CaPItal We use expertise and data to devel- op and market our products.',\n",
       " 'We develop and produce innovative medicines to address patient needs in disease areas where our experience and knowledge have the potential to produce transformative treatments.',\n",
       " '3 2019 highlights 4 Who we are 6 What we do 8 Message from the CEO Global Health & Corporate Responsibility at Novartis 9 13 Strategic areas Holding ourselves to the highest ethical standards 13 20 Being part of the solution onpricing and access 32 Addressing global healthchallenges 39 Being a responsible citizen 50 About this report 51 Performance indicators 2019 55 Novartis GRI Content Index Appendix: corporate responsibility material topic boundaries 59 Appendix: corporate responsibility materiality assessment issue cluster andtopic definitions Appendix: external initiatives and membership of associations Appendix: supplier spend 2019 Appendix: the responsible procurement (RP) risk indicator tool Appendix: measuring and valuing our impact Independent Assurance Report onthe 2019 Novartis in Society ESGreporting',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'We reimagine medicine to improve and extend peoples lives.',\n",
       " 'We use innovative science and technology to address some of societys most challenging healthcare issues.',\n",
       " 'The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis.',\n",
       " 'Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.',\n",
       " 'We made significant progress in global health, including on our efforts to elim- inate leprosy and malaria.',\n",
       " 'Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.',\n",
       " 'g INFRastRUCtURE aND FaCIlItIEs We own or lease research laborato- ries, manufacturing sites, offices and distribution facilities around the world.',\n",
       " 'The projected number of people in the world aged 65 or older by 2030, a 64% increase from 2015, according to the United Nations World Popula- tion Prospects',\n",
       " 'We strive to build trust with society through our efforts to operate with integrity, and to find new ways to expand patients access to our treatments.',\n",
       " 'We aspire to be a leader on environmental, social and governance topics and to build trust with society.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.',\n",
       " 'CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.',\n",
       " 'The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis.',\n",
       " ' tEChNOlOGY We use artificial intelligence, gene editing and other cutting-edge tech- nologies to spur innovation and increase efficiency.',\n",
       " 'At the same time, the worlds population continues to grow and people are living longer, fueling a rise in chronic diseases.',\n",
       " 'We are committed to taking real, meas- urable and reportable action in these key areas, and making sure that we communicate about them clearly and transparently.',\n",
       " 'These topics are at the core of the four GH&CR focus areas outlined above, and are covered in the following sections of this report.',\n",
       " 'Over the past 20 years, our company has evolved its approach to corporate responsibility, moving beyond philanthropic initiatives to strategically integrate access in our core business operations.',\n",
       " 'Our strategy rests on five pillars and is rooted in one of the five corporate pri- orities: building trust with society.',\n",
       " 'Our annual progress and aspirations for the future are reflected in this report, which is organized around our four key GH&CR focus areas:',\n",
       " 'One way we approach this is through our corporate responsibility materiality assessment to understand what matters to our stake- holders and how they perceive our impact.',\n",
       " 'We use innovative science and technology to address some of societys most challenging healthcare issues.',\n",
       " 'We also offer about 1 000 generic and bio- similar medicines covering a broad range of therapeutic areas.',\n",
       " 'The rise in the average yearly number of new drugs approved by the US FDAs Center for Drug Evaluation and Research from 2015-2019, compared to 2010-2014',\n",
       " 'The projected value of the global digital health market by 2023 (USD), a 60% increase from 2019, according to the Frost & Sullivan Global Digital Health Outlook 2020',\n",
       " 'We are rethinking how we work, embracing agile teams and building better productivity into our company to free resources that we can invest in innovation and help boost returns.',\n",
       " 'Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.',\n",
       " 'Theres much more to share, and our 2019 report provides an update on our commitments but more importantly on our actions.',\n",
       " 'We understand our contri- butions must be part of a larger social movement, as the challenges society faces are too great for any group or government to solve alone.',\n",
       " 'In 2019, we established a Trust & Reputation Com- mittee, which I personally chair, to review our ESG performance.',\n",
       " 'Within these clusters, priority topics were identified.',\n",
       " 'These topics are at the core of the four GH&CR focus areas outlined above, and are covered in the following sections of this report.',\n",
       " 'NGOs, government agencies, private sector firms, patient organizations, the media and health technology compa- nies to discuss strategies to achieve universal health coverage in Africa.',\n",
       " 'CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.',\n",
       " 'As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society.',\n",
       " 'Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.',\n",
       " 'Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'RElatIONshIPs We work with doctors to get effective treat- ments to patients.',\n",
       " 'Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.',\n",
       " 'Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'g INFRastRUCtURE aND FaCIlItIEs We own or lease research laborato- ries, manufacturing sites, offices and distribution facilities around the world.',\n",
       " 'Our products Our products address most major disease areas and are sold in approximately 155 countries around the world.',\n",
       " 'We are transforming our culture to ensure people can fully apply their talent and energy.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.',\n",
       " 'Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.',\n",
       " 'In 2019, we established a Trust & Reputation Com- mittee, which I personally chair, to review our ESG performance.',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'We use innovative science and technology to address some of societys most challenging healthcare issues.',\n",
       " 'Novartis Pharmaceuticals Novartis Pharmaceuticals focuses on patented treat - ments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'Cover photo Patients at Kumasi General Hospital in Ghana, where newborns are screened for sickle cell disease.',\n",
       " 'Only about 4% of babies in Ghana are tested for this debilitating genetic blood disorder.',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'Only about 4% of babies in Ghana are tested for this debilitating genetic blood disorder.',\n",
       " ' tEChNOlOGY We use artificial intelligence, gene editing and other cutting-edge tech- nologies to spur innovation and increase efficiency.',\n",
       " 'g INFRastRUCtURE aND FaCIlItIEs We own or lease research laborato- ries, manufacturing sites, offices and distribution facilities around the world.',\n",
       " 'We use innovative science and technology to address some of societys most challenging healthcare issues.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.',\n",
       " 'NIBR focuses on discovering new drugs that can change the practice of medicine.',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'Only about 4% of babies in Ghana are tested for this debilitating genetic blood disorder.',\n",
       " 'We reimagine medicine to improve and extend peoples lives.',\n",
       " 'RElatIONshIPs We work with doctors to get effective treat- ments to patients.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'INtEllECtUal CaPItal We use expertise and data to devel- op and market our products.',\n",
       " 'At the same time, the worlds population continues to grow and people are living longer, fueling a rise in chronic diseases.',\n",
       " 'We strive to build trust with society through our efforts to operate with integrity, and to find new ways to expand patients access to our treatments.',\n",
       " 'Cover photo Patients at Kumasi General Hospital in Ghana, where newborns are screened for sickle cell disease.',\n",
       " 'NOVARTIS BUSINESS SERVICES (NBS) consolidates support services across our organi- zation, helping drive effi- ciency, simplification, stan- dardization and quality.',\n",
       " 'NatURal CaPItal We consume energy, e r water and other resources to manu- facture our products and operate our business.',\n",
       " 'RElatIONshIPs We work with doctors to get effective treat- ments to patients.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'Novartis Pharmaceuticals Novartis Pharmaceuticals focuses on patented treat - ments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.',\n",
       " 'We also offer about 1 000 generic and bio- similar medicines covering a broad range of therapeutic areas.',\n",
       " 'The projected number of people in the world aged 65 or older by 2030, a 64% increase from 2015, according to the United Nations World Popula- tion Prospects',\n",
       " 'NIBR focuses on discovering new drugs that can change the practice of medicine.',\n",
       " 'We also announced plans to shift from maximiz- ing profit to maximizing access in sub- Saharan Africa, which has the worlds most underserved patient population.',\n",
       " 'We made significant progress in global health, including on our efforts to elim- inate leprosy and malaria.',\n",
       " 'Our teams also took important steps to help ensure we meet our com- mitment to become carbon neutral in our own operations by 2025.',\n",
       " 'We use innovative science and technology to address some of societys most challenging healthcare issues.',\n",
       " 'We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.',\n",
       " 'We partner with external organizations to ac- celerate drug discov- ery, develop business oppor tunities and ex- pand patient access.',\n",
       " 'FINaNCIal CaPItal We use cash, equity and debt to meet our financial com- mitments, make investments and pay dividends.',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'g INFRastRUCtURE aND FaCIlItIEs We own or lease research laborato- ries, manufacturing sites, offices and distribution facilities around the world.',\n",
       " 'Our manufacturing facilities produced 72 billion treatments in 2019.',\n",
       " 'We are transforming our culture to ensure people can fully apply their talent and energy.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'NOVARTIS BUSINESS SERVICES (NBS) consolidates support services across our organi- zation, helping drive effi- ciency, simplification, stan- dardization and quality.',\n",
       " 'Our environment We live in an era of amazing medical innovation, driven by better understanding of the genetic and biological roots of disease, and surging use of data analytics and digital technology in science and healthcare.',\n",
       " 'As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society.',\n",
       " 'Cover photo Patients at Kumasi General Hospital in Ghana, where newborns are screened for sickle cell disease.',\n",
       " 'Novartis Pharmaceuticals Novartis Pharmaceuticals focuses on patented treat - ments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.',\n",
       " 'RElatIONshIPs We work with doctors to get effective treat- ments to patients.',\n",
       " 'Our manufacturing facilities produced 72 billion treatments in 2019.',\n",
       " 'NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.',\n",
       " 'Our products Our products address most major disease areas and are sold in approximately 155 countries around the world.',\n",
       " 'The rise in the average yearly number of new drugs approved by the US FDAs Center for Drug Evaluation and Research from 2015-2019, compared to 2010-2014',\n",
       " 'We aim to spark a digital revolution at Novartis, embracing digital tech- no logies, advanced analytics and artificial intelligence to help drive innovation and improve efficiency.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'Cover photo Patients at Kumasi General Hospital in Ghana, where newborns are screened for sickle cell disease.',\n",
       " 'NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.',\n",
       " 'NOVARTIS BUSINESS SERVICES (NBS) consolidates support services across our organi- zation, helping drive effi- ciency, simplification, stan- dardization and quality.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'We use innovative science and technology to address some of societys most challenging healthcare issues.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.',\n",
       " 'NIBR focuses on discovering new drugs that can change the practice of medicine.',\n",
       " 'NatURal CaPItal We consume energy, e r water and other resources to manu- facture our products and operate our business.',\n",
       " 'INtEllECtUal CaPItal We use expertise and data to devel- op and market our products.',\n",
       " 'The rise in the average yearly number of new drugs approved by the US FDAs Center for Drug Evaluation and Research from 2015-2019, compared to 2010-2014',\n",
       " 'CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.',\n",
       " 'Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.',\n",
       " 'Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.',\n",
       " '1 Guide the implementation of the Novartis Access Principles in the areas of research and development (R&D), affordability and pricing, and health system strengthening',\n",
       " 'Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.',\n",
       " 'Only about 4% of babies in Ghana are tested for this debilitating genetic blood disorder.',\n",
       " 'We reimagine medicine to improve and extend peoples lives.',\n",
       " 'NIBR focuses on discovering new drugs that can change the practice of medicine.',\n",
       " 'Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.',\n",
       " 'We also aim to reward those who invest their money, time and ideas in our company.',\n",
       " 'Were creating an organization where people are inspired, curious and unbossed.',\n",
       " 'Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.']"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_data= []\n",
    "for i in range(len(topics_top_sentence_list)):\n",
    "    count = -1\n",
    "    for j in topics_top_sentence_list[i]:\n",
    "        if count == 3:\n",
    "            break\n",
    "        else:\n",
    "            test_data.append(j)\n",
    "            count = count+1\n",
    "test_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "c3574c11",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      " tEChNOlOGY We use artificial intelligence, gene editing and other cutting-edge tech- nologies to spur innovation and increase efficiency.\n",
      "Business Model and Innovation\n",
      "Artificial Intelligence\n",
      "Business Model Resilience\n",
      "Environment\n",
      "Systemic Risk Management\n",
      "_________________\n",
      "We develop and produce innovative medicines to address patient needs in disease areas where our experience and knowledge have the potential to produce transformative treatments.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Product Design and Lifecycle Management\n",
      "Customer Welfare\n",
      "Business Model Resilience\n",
      "_________________\n",
      "In our pursuit of trans- formative treatments, we challenge medical paradigms and explore possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to dramatically improve quality of life.\n",
      "Business Model and Innovation\n",
      "Systemic Risk Management\n",
      "Critical Incident Risk Management\n",
      "Leadership and Governance\n",
      "Business Model Resilience\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "Novartis Pharmaceuticals Novartis Pharmaceuticals focuses on patented treat - ments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Management of the Legal Regulatory Environment\n",
      "Selling Practices and Product Labeling\n",
      "Access and Affordability\n",
      "_________________\n",
      "Our products Our products address most major disease areas and are sold in approximately 155 countries around the world.\n",
      "Business Model and Product Labeling\n",
      "Access and Affordability\n",
      "Product Quality and Safety\n",
      "Product Labeling and Safety\n",
      "Management of the Legal Risk Management\n",
      "_________________\n",
      "The rise in the average yearly number of new drugs approved by the US FDAs Center for Drug Evaluation and Research from 2015-2019, compared to 2010-2014\n",
      "Selling Practices and Product Labeling\n",
      "Product Design and Lifecycle Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "We also offer about 1 000 generic and bio- similar medicines covering a broad range of therapeutic areas.\n",
      "Selling Practices and Product Labeling\n",
      "Competitive Behavior\n",
      "Access and Affordability\n",
      "Business Model and Product Labeling\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.\n",
      "Environment\n",
      "Environment and Governance\n",
      "Environmental Impact of Climate Change\n",
      "Environment for Community Relations\n",
      "Environment Resilience\n",
      "_________________\n",
      "Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.\n",
      "Human Rights and Community Relations\n",
      "Employee Health and Safety\n",
      "Human Capital\n",
      "Leadership and Governance\n",
      "Employee Benefits and Diversity\n",
      "_________________\n",
      "We understand our contri- butions must be part of a larger social movement, as the challenges society faces are too great for any group or government to solve alone.\n",
      "Social Capital\n",
      "Leadership and Governance\n",
      "Social Capital and Community Relations\n",
      "Business Model Resilience\n",
      "Socialism and Community Relations\n",
      "_________________\n",
      "We reimagine medicine to improve and extend peoples lives.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Business Model Resilience\n",
      "Medicine for the Health and Safety\n",
      "Customer Welfare and Community Relations\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "In our pursuit of trans- formative treatments, we challenge medical paradigms and explore possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to dramatically improve quality of life.\n",
      "Business Model and Innovation\n",
      "Systemic Risk Management\n",
      "Critical Incident Risk Management\n",
      "Leadership and Governance\n",
      "Business Model Resilience\n",
      "_________________\n",
      "We aim to spark a digital revolution at Novartis, embracing digital tech- no logies, advanced analytics and artificial intelligence to help drive innovation and improve efficiency.\n",
      "Business Model and Innovation\n",
      "Digital Innovation and Innovation\n",
      "Leadership and Governance\n",
      "Digital Transformation and Innovation\n",
      "Business Model and Governance\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "FINaNCIal CaPItal We use cash, equity and debt to meet our financial com- mitments, make investments and pay dividends.\n",
      "Business Model Resilience\n",
      "Business Model and Investment Management\n",
      "Capital Market Risk Management\n",
      "Management of the Financial System\n",
      "Business Model and Governance\n",
      "_________________\n",
      "NatURal CaPItal We consume energy, e r water and other resources to manu- facture our products and operate our business.\n",
      "Water & Wastewater Management\n",
      "Product Design and Lifecycle Management\n",
      "Business Ethics\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "RElatIONshIPs We work with doctors to get effective treat- ments to patients.\n",
      "Access and Affordability\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "INtEllECtUal CaPItal We use expertise and data to devel- op and market our products.\n",
      "Product Design and Lifecycle Management\n",
      "Product Design and Marketing\n",
      "Business Model Resilience\n",
      "Product Design and Marketability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "We develop and produce innovative medicines to address patient needs in disease areas where our experience and knowledge have the potential to produce transformative treatments.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Product Design and Lifecycle Management\n",
      "Customer Welfare\n",
      "Business Model Resilience\n",
      "_________________\n",
      "3 2019 highlights 4 Who we are 6 What we do 8 Message from the CEO Global Health & Corporate Responsibility at Novartis 9 13 Strategic areas Holding ourselves to the highest ethical standards 13 20 Being part of the solution onpricing and access 32 Addressing global healthchallenges 39 Being a responsible citizen 50 About this report 51 Performance indicators 2019 55 Novartis GRI Content Index Appendix: corporate responsibility material topic boundaries 59 Appendix: corporate responsibility materiality assessment issue cluster andtopic definitions Appendix: external initiatives and membership of associations Appendix: supplier spend 2019 Appendix: the responsible procurement (RP) risk indicator tool Appendix: measuring and valuing our impact Independent Assurance Report onthe 2019 Novartis in Society ESGreporting\n",
      "Supply Chain Management\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Employee Health and Safety\n",
      "Customer Welfare and Community Relations\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.\n",
      "Human Capital\n",
      "Human Capital and Business Ethics\n",
      "Leadership and Governance\n",
      "HR & Human Capital\n",
      "Human Capital and Community Relations\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "We reimagine medicine to improve and extend peoples lives.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Business Model Resilience\n",
      "Medicine for the Health and Safety\n",
      "Customer Welfare and Community Relations\n",
      "_________________\n",
      "We use innovative science and technology to address some of societys most challenging healthcare issues.\n",
      "Access and Affordability\n",
      "Access, and Affordability\n",
      "Access and Affordability Management\n",
      "Access & Affordability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis.\n",
      "Business Model and Innovation\n",
      "Business Model and Innovation Management\n",
      "BioMedical Innovation and Innovation\n",
      "Access and Affordability\n",
      "BioMedical Research and Innovation\n",
      "_________________\n",
      "Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.\n",
      "Environment\n",
      "Environment and Governance\n",
      "Environmental Impact of Climate Change\n",
      "Environment for Community Relations\n",
      "Environment Resilience\n",
      "_________________\n",
      "We made significant progress in global health, including on our efforts to elim- inate leprosy and malaria.\n",
      "Global Health and Safety\n",
      "Leadership and Governance\n",
      "Human Health and Safety\n",
      "Business Ethics\n",
      "Health and Safety\n",
      "_________________\n",
      "Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.\n",
      "Human Rights and Community Relations\n",
      "Employee Health and Safety\n",
      "Human Capital\n",
      "Leadership and Governance\n",
      "Employee Benefits and Diversity\n",
      "_________________\n",
      "g INFRastRUCtURE aND FaCIlItIEs We own or lease research laborato- ries, manufacturing sites, offices and distribution facilities around the world.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Research and Innovation\n",
      "Research and Development\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "The projected number of people in the world aged 65 or older by 2030, a 64% increase from 2015, according to the United Nations World Popula- tion Prospects\n",
      "Population Health and Safety\n",
      "Human Capital\n",
      "Business Model Resilience\n",
      "Global Health and Safety\n",
      "Population and Community Relations\n",
      "_________________\n",
      "We strive to build trust with society through our efforts to operate with integrity, and to find new ways to expand patients access to our treatments.\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Customer Welfare\n",
      "Business Ethics and Governance\n",
      "Business Ethics and Ethics\n",
      "_________________\n",
      "We aspire to be a leader on environmental, social and governance topics and to build trust with society.\n",
      "Leadership and Governance\n",
      "Social Capital\n",
      "Business Ethics\n",
      "Governance and Governance\n",
      "Global Governance and Governance\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.\n",
      "Business Model and Innovation\n",
      "Product Design and Lifecycle Management\n",
      "Selling Practices and Product Labeling\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "_________________\n",
      "CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.\n",
      "Human Capital\n",
      "Human Capital and Business Ethics\n",
      "Leadership and Governance\n",
      "HR & Human Capital\n",
      "Human Capital and Community Relations\n",
      "_________________\n",
      "The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis.\n",
      "Business Model and Innovation\n",
      "Business Model and Innovation Management\n",
      "BioMedical Innovation and Innovation\n",
      "Access and Affordability\n",
      "BioMedical Research and Innovation\n",
      "_________________\n",
      " tEChNOlOGY We use artificial intelligence, gene editing and other cutting-edge tech- nologies to spur innovation and increase efficiency.\n",
      "Business Model and Innovation\n",
      "Artificial Intelligence\n",
      "Business Model Resilience\n",
      "Environment\n",
      "Systemic Risk Management\n",
      "_________________\n",
      "At the same time, the worlds population continues to grow and people are living longer, fueling a rise in chronic diseases.\n",
      "Population Health and Safety\n",
      "Human Capital\n",
      "Global Health and Safety\n",
      "Business Model and Innovation\n",
      "Population Growth and Development\n",
      "_________________\n",
      "We are committed to taking real, meas- urable and reportable action in these key areas, and making sure that we communicate about them clearly and transparently.\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Customer Welfare\n",
      "Customer Privacy\n",
      "Customer Welfare and Security\n",
      "_________________\n",
      "These topics are at the core of the four GH&CR focus areas outlined above, and are covered in the following sections of this report.\n",
      "Human Capital\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Systemic Risk Management\n",
      "Customer Welfare and Community Relations\n",
      "_________________\n",
      "Over the past 20 years, our company has evolved its approach to corporate responsibility, moving beyond philanthropic initiatives to strategically integrate access in our core business operations.\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Systemic Risk Management\n",
      "Customer Welfare\n",
      "Human Capital\n",
      "_________________\n",
      "Our strategy rests on five pillars and is rooted in one of the five corporate pri- orities: building trust with society.\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Social Capital\n",
      "Customer Welfare\n",
      "Human Capital\n",
      "_________________\n",
      "Our annual progress and aspirations for the future are reflected in this report, which is organized around our four key GH&CR focus areas:\n",
      "Human Capital\n",
      "Access and Affordability\n",
      "Leadership and Governance\n",
      "Business Model and Innovation\n",
      "Economic Impacts of Climate Change\n",
      "_________________\n",
      "One way we approach this is through our corporate responsibility materiality assessment to understand what matters to our stake- holders and how they perceive our impact.\n",
      "Business Ethics\n",
      "Customer Welfare and Governance\n",
      "Physical Impact of Climate Change\n",
      "Customer Welfare\n",
      "Management of the Legal Environment\n",
      "_________________\n",
      "We use innovative science and technology to address some of societys most challenging healthcare issues.\n",
      "Access and Affordability\n",
      "Access, and Affordability\n",
      "Access and Affordability Management\n",
      "Access & Affordability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "We also offer about 1 000 generic and bio- similar medicines covering a broad range of therapeutic areas.\n",
      "Selling Practices and Product Labeling\n",
      "Competitive Behavior\n",
      "Access and Affordability\n",
      "Business Model and Product Labeling\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "The rise in the average yearly number of new drugs approved by the US FDAs Center for Drug Evaluation and Research from 2015-2019, compared to 2010-2014\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Selling Practices and Product Labeling\n",
      "Product Design and Lifecycle Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "The projected value of the global digital health market by 2023 (USD), a 60% increase from 2019, according to the Frost & Sullivan Global Digital Health Outlook 2020\n",
      "Business Model and Innovation\n",
      "Digital Health and Safety\n",
      "Business Model Resilience\n",
      "Digital Health and Human Capital\n",
      "Digital Health and Wellness\n",
      "_________________\n",
      "We are rethinking how we work, embracing agile teams and building better productivity into our company to free resources that we can invest in innovation and help boost returns.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model, Innovation and Innovation\n",
      "Business Model for Innovation and Innovation\n",
      "Business Model of Innovation and Innovation\n",
      "_________________\n",
      "Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.\n",
      "Energy Management\n",
      "Energy Management and Climate Change\n",
      "Energy Management and Efficiency\n",
      "Energy Management and Environment\n",
      "Energy Management and Sustainability\n",
      "_________________\n",
      "Theres much more to share, and our 2019 report provides an update on our commitments but more importantly on our actions.\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Business Model and Governance\n",
      "Human Capital\n",
      "Business Model Resilience\n",
      "_________________\n",
      "We understand our contri- butions must be part of a larger social movement, as the challenges society faces are too great for any group or government to solve alone.\n",
      "Social Capital\n",
      "Leadership and Governance\n",
      "Social Capital and Community Relations\n",
      "Business Model Resilience\n",
      "Socialism and Community Relations\n",
      "_________________\n",
      "In 2019, we established a Trust & Reputation Com- mittee, which I personally chair, to review our ESG performance.\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Customer Welfare\n",
      "Social Capital\n",
      "Trust and Trustworthiness\n",
      "_________________\n",
      "Within these clusters, priority topics were identified.\n",
      "Leadership and Governance\n",
      "Business Model and Governance\n",
      "Business Ethics\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "_________________\n",
      "These topics are at the core of the four GH&CR focus areas outlined above, and are covered in the following sections of this report.\n",
      "Human Capital\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Systemic Risk Management\n",
      "Customer Welfare and Community Relations\n",
      "_________________\n",
      "NGOs, government agencies, private sector firms, patient organizations, the media and health technology compa- nies to discuss strategies to achieve universal health coverage in Africa.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Health and Safety\n",
      "Human Rights and Community Relations\n",
      "Public Health and Safety\n",
      "_________________\n",
      "CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.\n",
      "Human Capital\n",
      "Human Capital and Business Ethics\n",
      "Leadership and Governance\n",
      "HR & Human Capital\n",
      "Human Capital and Community Relations\n",
      "_________________\n",
      "As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society.\n",
      "Business Ethics\n",
      "Business Model and Governance\n",
      "Business Model and Innovation\n",
      "Leadership and Governance\n",
      "Business Model and Leadership\n",
      "_________________\n",
      "Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.\n",
      "Environment\n",
      "Environment and Governance\n",
      "Environmental Impact of Climate Change\n",
      "Environment for Community Relations\n",
      "Environment Resilience\n",
      "_________________\n",
      "Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.\n",
      "Human Rights and Community Relations\n",
      "Employee Health and Safety\n",
      "Human Capital\n",
      "Leadership and Governance\n",
      "Employee Benefits and Diversity\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "RElatIONshIPs We work with doctors to get effective treat- ments to patients.\n",
      "Access and Affordability\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.\n",
      "Energy Management\n",
      "Energy Management and Climate Change\n",
      "Energy Management and Efficiency\n",
      "Energy Management and Environment\n",
      "Energy Management and Sustainability\n",
      "_________________\n",
      "Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.\n",
      "Human Rights and Community Relations\n",
      "Employee Health and Safety\n",
      "Human Capital\n",
      "Leadership and Governance\n",
      "Employee Benefits and Diversity\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "g INFRastRUCtURE aND FaCIlItIEs We own or lease research laborato- ries, manufacturing sites, offices and distribution facilities around the world.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Research and Innovation\n",
      "Research and Development\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "Our products Our products address most major disease areas and are sold in approximately 155 countries around the world.\n",
      "Business Model and Product Labeling\n",
      "Access and Affordability\n",
      "Product Quality and Safety\n",
      "Product Labeling and Safety\n",
      "Management of the Legal Risk Management\n",
      "_________________\n",
      "We are transforming our culture to ensure people can fully apply their talent and energy.\n",
      "Leadership and Governance\n",
      "Business Ethics\n",
      "Culture and Leadership\n",
      "Culture and Innovation\n",
      "Human Capital\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.\n",
      "Human Capital\n",
      "Human Capital and Business Ethics\n",
      "Leadership and Governance\n",
      "HR & Human Capital\n",
      "Human Capital and Community Relations\n",
      "_________________\n",
      "Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.\n",
      "Energy Management\n",
      "Energy Management and Climate Change\n",
      "Energy Management and Efficiency\n",
      "Energy Management and Environment\n",
      "Energy Management and Sustainability\n",
      "_________________\n",
      "In 2019, we established a Trust & Reputation Com- mittee, which I personally chair, to review our ESG performance.\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Customer Welfare\n",
      "Social Capital\n",
      "Trust and Trustworthiness\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "We use innovative science and technology to address some of societys most challenging healthcare issues.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Access and Affordability\n",
      "Access, and Affordability\n",
      "Access and Affordability Management\n",
      "Access & Affordability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "Novartis Pharmaceuticals Novartis Pharmaceuticals focuses on patented treat - ments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Management of the Legal Regulatory Environment\n",
      "Selling Practices and Product Labeling\n",
      "Access and Affordability\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "Cover photo Patients at Kumasi General Hospital in Ghana, where newborns are screened for sickle cell disease.\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Access and Affordability\n",
      "Employee Engagement, Diversity and Inclusion\n",
      "_________________\n",
      "Only about 4% of babies in Ghana are tested for this debilitating genetic blood disorder.\n",
      "Customer Welfare\n",
      "Systemic Risk Management\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Business Ethics\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "Only about 4% of babies in Ghana are tested for this debilitating genetic blood disorder.\n",
      "Customer Welfare\n",
      "Systemic Risk Management\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Business Ethics\n",
      "_________________\n",
      " tEChNOlOGY We use artificial intelligence, gene editing and other cutting-edge tech- nologies to spur innovation and increase efficiency.\n",
      "Business Model and Innovation\n",
      "Artificial Intelligence\n",
      "Business Model Resilience\n",
      "Environment\n",
      "Systemic Risk Management\n",
      "_________________\n",
      "g INFRastRUCtURE aND FaCIlItIEs We own or lease research laborato- ries, manufacturing sites, offices and distribution facilities around the world.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Research and Innovation\n",
      "Research and Development\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "We use innovative science and technology to address some of societys most challenging healthcare issues.\n",
      "Access and Affordability\n",
      "Access, and Affordability\n",
      "Access and Affordability Management\n",
      "Access & Affordability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.\n",
      "Business Model and Innovation\n",
      "Product Design and Lifecycle Management\n",
      "Selling Practices and Product Labeling\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "_________________\n",
      "NIBR focuses on discovering new drugs that can change the practice of medicine.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Business Model and Innovation in Medicine\n",
      "Product Design and Lifecycle Management\n",
      "Systemic Risk Management\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "Only about 4% of babies in Ghana are tested for this debilitating genetic blood disorder.\n",
      "Customer Welfare\n",
      "Systemic Risk Management\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Business Ethics\n",
      "_________________\n",
      "We reimagine medicine to improve and extend peoples lives.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Business Model Resilience\n",
      "Medicine for the Health and Safety\n",
      "Customer Welfare and Community Relations\n",
      "_________________\n",
      "RElatIONshIPs We work with doctors to get effective treat- ments to patients.\n",
      "Access and Affordability\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "INtEllECtUal CaPItal We use expertise and data to devel- op and market our products.\n",
      "Product Design and Lifecycle Management\n",
      "Product Design and Marketing\n",
      "Business Model Resilience\n",
      "Product Design and Marketability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "At the same time, the worlds population continues to grow and people are living longer, fueling a rise in chronic diseases.\n",
      "Population Health and Safety\n",
      "Human Capital\n",
      "Global Health and Safety\n",
      "Business Model and Innovation\n",
      "Population Growth and Development\n",
      "_________________\n",
      "We strive to build trust with society through our efforts to operate with integrity, and to find new ways to expand patients access to our treatments.\n",
      "Business Ethics\n",
      "Leadership and Governance\n",
      "Customer Welfare\n",
      "Business Ethics and Governance\n",
      "Business Ethics and Ethics\n",
      "_________________\n",
      "Cover photo Patients at Kumasi General Hospital in Ghana, where newborns are screened for sickle cell disease.\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Access and Affordability\n",
      "Employee Engagement, Diversity and Inclusion\n",
      "_________________\n",
      "NOVARTIS BUSINESS SERVICES (NBS) consolidates support services across our organi- zation, helping drive effi- ciency, simplification, stan- dardization and quality.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Business Model and Governance\n",
      "Business Ethics\n",
      "Business Model and Business Ethics\n",
      "_________________\n",
      "NatURal CaPItal We consume energy, e r water and other resources to manu- facture our products and operate our business.\n",
      "Water & Wastewater Management\n",
      "Product Design and Lifecycle Management\n",
      "Business Ethics\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "RElatIONshIPs We work with doctors to get effective treat- ments to patients.\n",
      "Access and Affordability\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "Novartis Pharmaceuticals Novartis Pharmaceuticals focuses on patented treat - ments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Management of the Legal Regulatory Environment\n",
      "Selling Practices and Product Labeling\n",
      "Access and Affordability\n",
      "_________________\n",
      "We also offer about 1 000 generic and bio- similar medicines covering a broad range of therapeutic areas.\n",
      "Selling Practices and Product Labeling\n",
      "Competitive Behavior\n",
      "Access and Affordability\n",
      "Business Model and Product Labeling\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "The projected number of people in the world aged 65 or older by 2030, a 64% increase from 2015, according to the United Nations World Popula- tion Prospects\n",
      "Population Health and Safety\n",
      "Human Capital\n",
      "Business Model Resilience\n",
      "Global Health and Safety\n",
      "Population and Community Relations\n",
      "_________________\n",
      "NIBR focuses on discovering new drugs that can change the practice of medicine.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Business Model and Innovation in Medicine\n",
      "Product Design and Lifecycle Management\n",
      "Systemic Risk Management\n",
      "_________________\n",
      "We also announced plans to shift from maximiz- ing profit to maximizing access in sub- Saharan Africa, which has the worlds most underserved patient population.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Systemic Risk Management\n",
      "Access and Accessibility\n",
      "Business Model and Governance\n",
      "_________________\n",
      "We made significant progress in global health, including on our efforts to elim- inate leprosy and malaria.\n",
      "Global Health and Safety\n",
      "Leadership and Governance\n",
      "Human Health and Safety\n",
      "Business Ethics\n",
      "Health and Safety\n",
      "_________________\n",
      "Our teams also took important steps to help ensure we meet our com- mitment to become carbon neutral in our own operations by 2025.\n",
      "GHG Emissions\n",
      "Physical Impacts of Climate Change\n",
      "Air Quality\n",
      "Business Ethics\n",
      "Energy Management\n",
      "_________________\n",
      "We use innovative science and technology to address some of societys most challenging healthcare issues.\n",
      "Access and Affordability\n",
      "Access, and Affordability\n",
      "Access and Affordability Management\n",
      "Access & Affordability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.\n",
      "Business Model and Innovation\n",
      "Business Model and Innovation & Innovation\n",
      "Business Model Resilience\n",
      "Business Model Resilience and Innovation\n",
      "Business Model and Innovation Model of Innovation\n",
      "_________________\n",
      "We partner with external organizations to ac- celerate drug discov- ery, develop business oppor tunities and ex- pand patient access.\n",
      "Access and Affordability\n",
      "Access and Affordability Research and Innovation\n",
      "Access & Affordability\n",
      "Access and Affordability Regulatory Environment\n",
      "Access to and Affordability\n",
      "_________________\n",
      "FINaNCIal CaPItal We use cash, equity and debt to meet our financial com- mitments, make investments and pay dividends.\n",
      "Business Model Resilience\n",
      "Business Model and Investment Management\n",
      "Capital Market Risk Management\n",
      "Management of the Financial System\n",
      "Business Model and Governance\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "g INFRastRUCtURE aND FaCIlItIEs We own or lease research laborato- ries, manufacturing sites, offices and distribution facilities around the world.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Research and Innovation\n",
      "Research and Development\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "Our manufacturing facilities produced 72 billion treatments in 2019.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Systemic Risk Management\n",
      "Business Ethics\n",
      "_________________\n",
      "We are transforming our culture to ensure people can fully apply their talent and energy.\n",
      "Leadership and Governance\n",
      "Business Ethics\n",
      "Culture and Leadership\n",
      "Culture and Innovation\n",
      "Human Capital\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "NOVARTIS BUSINESS SERVICES (NBS) consolidates support services across our organi- zation, helping drive effi- ciency, simplification, stan- dardization and quality.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Business Model and Governance\n",
      "Business Ethics\n",
      "Business Model and Business Ethics\n",
      "_________________\n",
      "Our environment We live in an era of amazing medical innovation, driven by better understanding of the genetic and biological roots of disease, and surging use of data analytics and digital technology in science and healthcare.\n",
      "Environment\n",
      "Environmental Impacts of Climate Change\n",
      "Environmental Impacts of Disease Control\n",
      "Environment and Health and Safety\n",
      "Environment and Innovation\n",
      "_________________\n",
      "As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society.\n",
      "Business Ethics\n",
      "Business Model and Governance\n",
      "Business Model and Innovation\n",
      "Leadership and Governance\n",
      "Business Model and Leadership\n",
      "_________________\n",
      "Cover photo Patients at Kumasi General Hospital in Ghana, where newborns are screened for sickle cell disease.\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Access and Affordability\n",
      "Employee Engagement, Diversity and Inclusion\n",
      "_________________\n",
      "Novartis Pharmaceuticals Novartis Pharmaceuticals focuses on patented treat - ments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Management of the Legal Regulatory Environment\n",
      "Selling Practices and Product Labeling\n",
      "Access and Affordability\n",
      "_________________\n",
      "RElatIONshIPs We work with doctors to get effective treat- ments to patients.\n",
      "Access and Affordability\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "Our manufacturing facilities produced 72 billion treatments in 2019.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Systemic Risk Management\n",
      "Business Ethics\n",
      "_________________\n",
      "NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.\n",
      "Business Model and Innovation\n",
      "Product Design and Lifecycle Management\n",
      "Selling Practices and Product Labeling\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "_________________\n",
      "Our products Our products address most major disease areas and are sold in approximately 155 countries around the world.\n",
      "Business Model and Product Labeling\n",
      "Access and Affordability\n",
      "Product Quality and Safety\n",
      "Product Labeling and Safety\n",
      "Management of the Legal Risk Management\n",
      "_________________\n",
      "The rise in the average yearly number of new drugs approved by the US FDAs Center for Drug Evaluation and Research from 2015-2019, compared to 2010-2014\n",
      "Selling Practices and Product Labeling\n",
      "Product Design and Lifecycle Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "We aim to spark a digital revolution at Novartis, embracing digital tech- no logies, advanced analytics and artificial intelligence to help drive innovation and improve efficiency.\n",
      "Business Model and Innovation\n",
      "Digital Innovation and Innovation\n",
      "Leadership and Governance\n",
      "Digital Transformation and Innovation\n",
      "Business Model and Governance\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "Cover photo Patients at Kumasi General Hospital in Ghana, where newborns are screened for sickle cell disease.\n",
      "Selling Practices and Product Labeling\n",
      "Systemic Risk Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Access and Affordability\n",
      "Employee Engagement, Diversity and Inclusion\n",
      "_________________\n",
      "NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.\n",
      "Business Model and Innovation\n",
      "Product Design and Lifecycle Management\n",
      "Selling Practices and Product Labeling\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "_________________\n",
      "NOVARTIS BUSINESS SERVICES (NBS) consolidates support services across our organi- zation, helping drive effi- ciency, simplification, stan- dardization and quality.\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Business Model and Governance\n",
      "Business Ethics\n",
      "Business Model and Business Ethics\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "We use innovative science and technology to address some of societys most challenging healthcare issues.\n",
      "Access and Affordability\n",
      "Access, and Affordability\n",
      "Access and Affordability Management\n",
      "Access & Affordability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "NOVARTIS TECHNICAL OPERATIONS (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.\n",
      "Business Model and Innovation\n",
      "Product Design and Lifecycle Management\n",
      "Selling Practices and Product Labeling\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "_________________\n",
      "NIBR focuses on discovering new drugs that can change the practice of medicine.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Business Model and Innovation in Medicine\n",
      "Product Design and Lifecycle Management\n",
      "Systemic Risk Management\n",
      "_________________\n",
      "NatURal CaPItal We consume energy, e r water and other resources to manu- facture our products and operate our business.\n",
      "Water & Wastewater Management\n",
      "Product Design and Lifecycle Management\n",
      "Business Ethics\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "INtEllECtUal CaPItal We use expertise and data to devel- op and market our products.\n",
      "Product Design and Lifecycle Management\n",
      "Product Design and Marketing\n",
      "Business Model Resilience\n",
      "Product Design and Marketability\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "The rise in the average yearly number of new drugs approved by the US FDAs Center for Drug Evaluation and Research from 2015-2019, compared to 2010-2014\n",
      "Selling Practices and Product Labeling\n",
      "Product Design and Lifecycle Management\n",
      "Management of the Legal Regulatory Environment\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "CORPORATE FUNCTIONS support the enterprise in specific areas of expertise, including finance, human resources, legal and commu- nications.\n",
      "Human Capital\n",
      "Human Capital and Business Ethics\n",
      "Leadership and Governance\n",
      "HR & Human Capital\n",
      "Human Capital and Community Relations\n",
      "_________________\n",
      "Our ESG-related commitments are not add-ons to our business they perme- ate Novartis to the core and we are owning this journey at the most senior levels of the company.\n",
      "Energy Management\n",
      "Energy Management and Climate Change\n",
      "Energy Management and Efficiency\n",
      "Energy Management and Environment\n",
      "Energy Management and Sustainability\n",
      "_________________\n",
      "Related to responsible citizenship, we made significant progress toward making good on the promises we made in signing the UN Equal Pay Interna- tional Coalition (EPIC) pledge for pay equity.\n",
      "Human Rights and Community Relations\n",
      "Employee Health and Safety\n",
      "Human Capital\n",
      "Leadership and Governance\n",
      "Employee Benefits and Diversity\n",
      "_________________\n",
      "1 Guide the implementation of the Novartis Access Principles in the areas of research and development (R&D), affordability and pricing, and health system strengthening\n",
      "Access and Affordability\n",
      "Accessibility and Affordability\n",
      "Business Model Resilience\n",
      "Access and Affordability Management\n",
      "Business Model and Innovation\n",
      "_________________\n",
      "Photo A worker at Ziplines distribution center in Omenako, Ghana, prepares a medical order for drone delivery.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Ethics\n",
      "Customer Welfare\n",
      "Business Modeling and Innovation\n",
      "_________________\n",
      "Only about 4% of babies in Ghana are tested for this debilitating genetic blood disorder.\n",
      "Customer Welfare\n",
      "Systemic Risk Management\n",
      "Business Model Resilience\n",
      "Business Model and Innovation\n",
      "Business Ethics\n",
      "_________________\n",
      "We reimagine medicine to improve and extend peoples lives.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Business Model Resilience\n",
      "Medicine for the Health and Safety\n",
      "Customer Welfare and Community Relations\n",
      "_________________\n",
      "NIBR focuses on discovering new drugs that can change the practice of medicine.\n",
      "Business Model and Innovation\n",
      "Access and Affordability\n",
      "Business Model and Innovation in Medicine\n",
      "Product Design and Lifecycle Management\n",
      "Systemic Risk Management\n",
      "_________________\n",
      "Novartis has partnered with Zipline, a US-based automated logistics company, to help deliver vital medicines to remote areas.\n",
      "Business Model and Innovation\n",
      "Business Model Resilience\n",
      "Business Model & Innovation\n",
      "Business Model and Technology\n",
      "Business Model and Product Design\n",
      "_________________\n",
      "We also aim to reward those who invest their money, time and ideas in our company.\n",
      "Customer Welfare\n",
      "Customer Welfare and Community Relations\n",
      "Customer Welfare and Welfare\n",
      "Customer Welfare and Employee Welfare\n",
      "Customer Welfare and Diversity\n",
      "_________________\n",
      "Were creating an organization where people are inspired, curious and unbossed.\n",
      "Leadership and Governance\n",
      "Business Ethics\n",
      "Business Model and Innovation\n",
      "Customer Welfare\n",
      "Human Capital\n",
      "_________________\n",
      "Thank you for taking the time to learn more about how Novartis continues to make meaningful progress on environ- mental, social and governance (ESG) topics.\n",
      "Environment\n",
      "Environment and Governance\n",
      "Environmental Impact of Climate Change\n",
      "Environment for Community Relations\n",
      "Environment Resilience\n",
      "_________________\n"
     ]
    }
   ],
   "source": [
    "with open('sentence_to_topic.txt', 'w', encoding=\"utf-8\") as file: \n",
    "    for i in test_data:\n",
    "        print(i)\n",
    "        file.write(\"Sentence : \"+i+\"\\n\")\n",
    "        file.write(\"Topic : \\n\")\n",
    "        test_sent = 'shorten: '+i\n",
    "        test_tokenized = tokenizer.encode_plus(test_sent, return_tensors=\"pt\")\n",
    "\n",
    "        test_input_ids  = test_tokenized[\"input_ids\"]\n",
    "        test_attention_mask = test_tokenized[\"attention_mask\"]\n",
    "\n",
    "        t5_model.eval()\n",
    "        beam_outputs = t5_model.generate(\n",
    "            input_ids=test_input_ids,attention_mask=test_attention_mask,\n",
    "            max_length=64,\n",
    "            early_stopping=True,\n",
    "            num_beams=10,\n",
    "            num_return_sequences=5,\n",
    "            no_repeat_ngram_size=2\n",
    "        )\n",
    "\n",
    "        for beam_output in beam_outputs:\n",
    "            sent = tokenizer.decode(beam_output, skip_special_tokens=True,clean_up_tokenization_spaces=True)\n",
    "            file.write(sent+\"\\n\")\n",
    "            print (sent)\n",
    "        file.write(\"\\n\")\n",
    "        file.write(\"---------------------------------------------------------------------------------------------\\n\\n\")\n",
    "        print(\"_________________\")\n",
    "    file.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d178222d",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "T5",
   "language": "python",
   "name": "t5"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
